Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy OKYO Pharma stock in Canada

OKYO Pharma stock has moved 1.45% from yesterday's closing price. Learn how to easily invest in OKYO Pharma stock.

OKYO Pharma is a biotechnology business based in the US. OKYO Pharma stocks (OKYO.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.07 – a decrease of 2.33% over the previous week. OKYO Pharma employs 6 staff and has a market cap (total outstanding stock value) of $41.8 million.

How to buy stocks in OKYO Pharma

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – OKYO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

OKYO Pharma stock price (NASDAQ:OKYO)

Use our graph to track the performance of OKYO stocks over time.

OKYO Pharma shares at a glance

Information last updated 2022-06-03.
Latest market close$2.10
52-week range$1.92 - $6.11
50-day moving average $2.51
200-day moving average $2.51
Wall St. target priceN/A
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.01

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
CIBC Investor's Edge
Finder Rating:
4 / 5
$0 if conditions met, otherwise $100 a year
Stocks, Bonds, Options, Mutual Funds, ETFs
Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
Scotia iTRADE
Finder Rating:
3.8 / 5
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Finder Rating:
3.9 / 5
Stocks, ETFs
Get $25 when you open a Wealthsimple account and fund at least $150.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get almost $500 in commission free trades when you fund your new account with a minimum of $10,000. Conditions apply. Ends August 31, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy OKYO Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

OKYO Pharma price performance over time

Historical closes compared with the close of $2.1 from 2022-06-27

1 week (2022-06-21) -2.33%
1 month (2022-05-27) 3.45%
3 months (2022-03-24) N/A
6 months (2021-12-24) N/A
1 year (2021-06-24) N/A
2 years (2020-06-24) N/A
3 years (2019-06-24) N/A
5 years (2017-06-24) N/A

OKYO Pharma financials

Gross profit TTM $-1,987,367
Return on assets TTM -56.73%
Return on equity TTM -94.71%
Profit margin 0%
Book value $0.00
Market capitalisation $41.8 million

TTM: trailing 12 months

OKYO Pharma share dividends

We're not expecting OKYO Pharma to pay a dividend over the next 12 months.

OKYO Pharma share price volatility

Over the last 12 months, OKYO Pharma's shares have ranged in value from as little as $1.92 up to $6.11. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OKYO Pharma's is 0.2697. This would suggest that OKYO Pharma's shares are less volatile than average (for this exchange).

OKYO Pharma overview

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. It is developing OK-101 for the treatment of dry eye disease; and OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. The company is also developing chemerin and chemerin analogues to treat the cytokine release syndrome associated with COVID-19 infections and other conditions, such as acute respiratory distress syndrome. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom. .

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site